Clinical Trial Update: MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC [Phase 1]

View source ↗

Summary

A Phase 1 trial of Adaptimmune's MAGE-A10 796T T-cell receptor therapy for advanced non-small cell lung cancer has completed the Phase 1 stage (status: complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• MAGE-A10 796T TCR therapy (MAGE-A10 targeted T-cell receptor therapy)

Snippet

Sponsor: Adaptimmune | Conditions: Non-Small Cell Lung Cancer, Carcinoma | Phase 1 | Status: COMPLETED